Envarsus XR 4 MG tablet 100S
Ended Awarded
- Contract number
- SPE2DR26FQQ5K
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,825
Award facts
- Contract value 100% obligated
- $10,824.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order contract by the Defense Logistics Agency (DLA) on November 20, 2025, for the supply of Envarsus XR 4 mg tablets (100-count units) with a ceiling value of $10,824.78 and firm fixed pricing. The contract is non-set-aside and competitively awarded, with an ultimate completion date of December 12, 2025. AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania serves as the place of performance. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive portfolio of pharmaceutical products and medical supplies to military and veteran healthcare systems through the DLA's Medical Supply Chain. The Envarsus XR delivery represents the company's ongoing role in providing specialized medications across multiple therapeutic domains to support Defense Health Agency and other federal healthcare customers. This contract reflects AmerisourceBergen's established capability to meet federal procurement requirements through open competition, consistent with its extensive history of competitively awarded delivery orders across the DLA's pharmaceutical supply network.
Quick answers
Who was awarded contract SPE2DR26FQQ5K?
SPE2DR26FQQ5K was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 20, 2025.
How much is contract SPE2DR26FQQ5K worth?
The government has obligated $10,825 on SPE2DR26FQQ5K.
Is contract SPE2DR26FQQ5K an order under another contract?
Yes. SPE2DR26FQQ5K is a delivery order under SPE2DR25D1022, an indefinite delivery contract.
Was contract SPE2DR26FQQ5K competed?
The extent of competition for SPE2DR26FQQ5K was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award